|
2023
|
Invention
|
Anti-ctla4 antibodies and methods of making and using the same.
Provided herein are cross-reacti... |
|
|
Invention
|
Dynamic human heavy chain antibody libraries.
Provided herein are libraries containing polynucle... |
|
|
Invention
|
Activatable antibodies and methods of making and using thereof.
Provided herein are libraries co... |
|
|
Invention
|
Dynamic human antibody light chain libraries.
Provided herein are libraries containing polynucle... |
|
2022
|
Invention
|
Combination therapies for treating cancer.
Provided herein are compositions and methods for trea... |
|
|
Invention
|
Combination therapies for treating cancer. Provided herein are compositions and methods for treat... |
|
2021
|
Invention
|
Anti-cd137 molecules and use thereof.
The present disclosure provides antibodies that bind to hu... |
|
2020
|
Invention
|
Anti-cd137l antibodies and methods of using same. Provided herein are antibodies that bind to an ... |
|
2019
|
Invention
|
Anti-pd-l1 antibodies and use thereof. The present disclosure provides antibodies that bind to th... |
|
|
Invention
|
Masked activatable cd137 antibodies. Provided herein are libraries containing synthetic polynucle... |
|
|
Invention
|
Anti-ctla4 antibodies and methods of making and using the same. Provided herein are cross-reactiv... |
|
|
Invention
|
Activatable antibodies and methods of making and using thereof. Provided herein are libraries con... |
|
|
Invention
|
Activatable antibodies and methods of making and using thereof. CA 3090027 2020-07-29(12) I... |
|
|
Invention
|
Precision/context-dependent activatable antibodies, and methods of making and using the same.
Pr... |
|
2018
|
Invention
|
Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody.
Provided h... |
|
|
Invention
|
Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody. Provided he... |
|
|
Invention
|
Method for treating cancer using anti-cd137 antibody. Provided are antibodies that bind to human ... |
|
|
Invention
|
Anti-cd137 molecules and use thereof. Provided are antibodies that bind to human CD137 or antigen... |
|
|
Invention
|
Precision/context-dependent activatable antibodies, and methods of making and using the same. Pro... |
|
2017
|
Invention
|
Methods for using cd137 ligand as biomarker for treatment with anti-cd137 antibody. Provided here... |
|
|
Invention
|
Dynamic human antibody light chain libraries. Provided herein are libraries containing polynucleo... |
|
|
Invention
|
Dynamic human heavy chain antibody libraries. Provided herein are libraries containing polynucleo... |
|
|
Invention
|
Dynamic human antibody light chain libraries. Provided herein are libraries containing poly... |
|
|
Invention
|
Anti-cd137 molecules and use thereof. The present disclosure provides antibodies that bind to hum... |
|
2014
|
Invention
|
Methods and systems for autoinduction of protein expression. Methods and systems for autoinductio... |
|
2013
|
Invention
|
An integrated system for library construction, affinity binder screening and expression thereof. ... |
